IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Corbus Pharmaceuticals Hldgs COM

CUSIP: 021833P13 | 1 institutional holders

Quarters

Q3 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2018

ETF Managers Group, LLC3,161,514
0.0% of portfolio›$22.8K
StyleTurnoverLocationFiled
ETF Managers Group, LLC
3,161,514$22.8K0.0%N/AN/ASummit, NJ2018-11-14